Antihypertensive Drug Safety During Pregnancy

Selecting antihypertensive medications during pregnancy requires careful consideration of maternal and fetal safety. Some common classes have known risks.

Evaluating Drug Safety in Pregnancy

• Labetalol: Generally considered safe and often a first-line agent for hypertension in pregnancy.
• Alpha-methyl dopa: A well-established and historically safe option for managing hypertension during pregnancy.
• Nifedipine: A calcium channel blocker that is typically considered safe for use in pregnant patients with hypertension.
• ACE-inhibitors: These drugs (e.g., enalapril, lisinopril) are contraindicated during pregnancy, particularly in the second and third trimesters. They are associated with significant fetal risks, including renal dysplasia, oligohydramnios, and fetal death.

Conclusion on Unsafe Antihypertensives

Based on established safety profiles, ACE-inhibitors pose significant teratogenic risks and are not safe for use during pregnancy. The other listed options are generally considered appropriate choices under medical supervision.